Home
Conditions
Neurodegenerative Diseases

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,031 public trials 1,769 recruiting studies

Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)

NCT02591901

Conditions: Antibiotic Resistance, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +34 more
Locations: Stoke Mandeville Hospital Aylesbury, Buckinghamshire, United Kingdom

Oxford Centre for Enablement Oxford, Oxfordshire, United Kingdom

View Trial Details

Completed

GADGET-PD Genetic and Digital Diagnosis of Essential Tremor and Parkinson's Disease Trial

NCT02668835

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

Two Resistance Training Protocols to Reduce the Risk of Falls in Parkinson's Disease

NCT02476266

Conditions: Accidental Falls, Basal Ganglia Diseases, Brain Diseases, +8 more
Locations: Sunlife Financial Movement Disorders Research and Rehabilitation Centre- Wilfrid Laurier University Waterloo, Ontario, Canada

View Trial Details

Completed

The Effect of Spinal Stabilization Exercises in Patients With Myasthenia Gravis

NCT03743740

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations: Hacettepe University Ankara, Turkey (Türkiye)

View Trial Details

Completed

Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients

NCT03162874

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Universitätsklinik für Innere Medizin VI Innsbruck, Neurologisches Studienzentrum Innsbruck, Austria

Centre Hospitalier Universitaire d'Amiens Amiens, France

Centre Hospitalier de la Côte Basque Bayonne, France

Hôpital Avicenne APHP Bobigny, France

View all 45 locations

View Trial Details

Completed

Dose Escalation Study of Cu(II)ATSM in Parkinson's Disease

NCT03204929

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Macquarie University Macquarie Park, New South Wales, Australia

The Royal Melbourne Hospital Melbourne, Victoria, Australia

View Trial Details

Completed

Effect of Implant Position on Magnetic Resonance Image Distortion

NCT02246231

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +25 more
Locations: Central Manchester University Hospitals NHS Foundation Trust Manchester, Manchester (Manchester Borough), United Kingdom

View Trial Details

Completed

Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND

NCT02870634

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Macquarie University Sydenham, New South Wales, Australia

Calvary Health Care Bethlehem Caulfield, Victoria, Australia

View Trial Details

Completed

Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) Patients

NCT02551809

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Kaohsiung Chang Gung Memorial Hospital (KS-CGMH) Kaohsiung City, Taiwan

National Taiwan University Hospital (NTUH) Taipei, Taiwan

Taipei Veterans General Hospital (TVGH) Taipei, Taiwan

Linkou Chang Gung Memorial Hospital (LK-CGMH) Taoyuan, Taiwan

View Trial Details

Completed

Continuation Treatment Protocol for Patient Who Participated in the BIA 9-1067-302 Clinical Trial

NCT01851850

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations: Rabin Medical Center Petach Tiqva, Central District, Israel

View Trial Details

Neurodegenerative Diseases

Neurodegenerative Diseases trial results

Related conditions